Stable rasagiline composition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8859624
APP PUB NO 20120214877A1
SERIAL NO

13504178

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a stable composition of rasagiline comprising an effective dosage of rasagiline or its pharmaceutically acceptable salts and an antioxidant used as a stabilizer. The dosage forms of the composition are pharmaceutically common transdermal-drug delivery dosage form and mucoadhesive delivery dosage form, such as patch, gel, ointment, cream, cataplasm, film, spray and solution, etc. The composition can be used to prevent or treat mental disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE CO LTD400061 NO 565 TU SHAN ROAD NAN'AN DISTRICT CHONGQING MUNICIPAL DISTRICT CHONGQING CITY 400061

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Hao Chongqing, CN 1012 6150
Deng, Jie Chongqing, CN 62 1067
Lin, Jialiang Chongqing, CN 3 18
Zhang, Tao Chongqing, CN 1018 9317

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 14, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00